Chemo India Formulations, a subsidiary of Spanish drug company Chemo Group, has opened its first R&D and pharmaceutical manufacturing facility with an initial investment of Rs 100 crore in Hyderabad. The company plans to produce oral solid dosage forms, including tablets, caplets, hard gelatin capsules and pellets.
"This is only the first step. We plan to invest more in India," Chemo Group managing director Lucas Sigman said on Wednesday.
The group is present in over 40 countries and has around 6,000 employees across 15 plants, 10 R&D centres and 33 affiliated companies, according to the company.